REATA PHARMACEUTICALS INC Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2015 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Reata Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2015 to Q2 2023.
  • Reata Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2023 was 37.7M shares, a 3.3% increase year-over-year.
  • Reata Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 36.5M shares, a 0.54% increase from 2021.
  • Reata Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 36.3M shares, a 7.75% increase from 2020.
  • Reata Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 33.7M shares, a 10.8% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 37.7M +1.2M +3.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 36.9M +535K +1.47% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-10
Q4 2022 36.5M +197K +0.54% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-24
Q3 2022 36.5M +149K +0.41% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 36.5M +168K +0.46% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 36.4M +209K +0.58% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 36.3M +2.61M +7.75% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 36.4M +2.67M +7.93% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 36.3M +3.03M +9.12% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 36.2M +2.98M +8.98% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-06
Q4 2020 33.7M +3.3M +10.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 33.7M +3.6M +12% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 33.3M +3.2M +10.6% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 33.2M +3.39M +11.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 30.4M +2.71M +9.79% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 30.1M +1.41M +4.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 30.1M +3.89M +14.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 29.8M +3.67M +14.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 27.7M +3.77M +15.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 28.7M +3.86M +15.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 26.2M +3.81M +17% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 26.2M +3.8M +17% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 23.9M +4.12M +20.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 24.8M +2.52M +11.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 22.4M +3.8M +20.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 22.4M +6.36M +39.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 19.8M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 22.3M +6.34M +39.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 18.6M +2.59M +16.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 16M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q3 2015 16M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 16M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.